FabRx performs World’s First Clinical Study to Bring Personalised Patient Treatment by 3D Printing of Pharmaceuticals
FabRx, a leader in 3D printing of pharmaceuticals, has successfully accomplished the world’s first in-human clinical study using their proprietary Printlets™ technology. This pioneering study will